Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PET Metabolic Activity, Clinical Stages, and Survival Outcome.

Chih-Kai ChangTiffany Ting-Fang ShihYu-Wen TienMing-Chu ChangYu-Ting ChangShih-Hung YangMei-Fang ChengBang-Bin Chen

Published in: Diagnostics (Basel, Switzerland) (2021)

Decreased MRS metabolites in pancreatic cancer were associated with poor survival outcome, and may be used as prognostic image biomarkers for these patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
computed tomography
ms ms
prognostic factors
high resolution
free survival
single molecule
positron emission tomography
pet imaging